28 related articles for article (PubMed ID: 20694696)
1. Advantages of Molecular Weight Identification during Native MS Screening.
Khan A; Bresnick A; Cahill S; Girvin M; Almo S; Quinn R
Planta Med; 2018 Nov; 84(16):1201-1212. PubMed ID: 29742762
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cysteinylation of pharmaceutical-grade human serum albumin by electrospray ionization mass spectrometry and low-energy collision-induced dissociation tandem mass spectrometry.
Kleinova M; Belgacem O; Pock K; Rizzi A; Buchacher A; Allmaier G
Rapid Commun Mass Spectrom; 2005; 19(20):2965-73. PubMed ID: 16178042
[TBL] [Abstract][Full Text] [Related]
3. Drug screening of pharmaceutical discovery compounds by micro-size exclusion chromatography/mass spectrometry.
Wabnitz PA; Loo JA
Rapid Commun Mass Spectrom; 2002; 16(2):85-91. PubMed ID: 11754252
[TBL] [Abstract][Full Text] [Related]
4. Use of a five-channel multiplexed electrospray quadrupole time-of-flight hybrid mass spectrometer for metabolite identification.
Leclercq L; Delatour C; Hoes I; Brunelle F; Labrique X; Castro-Perez J
Rapid Commun Mass Spectrom; 2005; 19(12):1611-8. PubMed ID: 15915450
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of monoterpene glycosides extracted from Paeonia lactiflora Pall. using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry and high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Dong H; Liu Z; Song F; Yu Z; Li H; Liu S
Rapid Commun Mass Spectrom; 2007; 21(19):3193-9. PubMed ID: 17764105
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI).
Juan H; Zhiling Z; Huande L
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jun; 820(1):33-9. PubMed ID: 15866490
[TBL] [Abstract][Full Text] [Related]
7. GPC spin column HPLC-ESI-MS methods for screening drugs noncovalently bound to proteins.
Siegel MM
Methods Mol Biol; 2009; 572():231-45. PubMed ID: 20694696
[TBL] [Abstract][Full Text] [Related]
8. Early discovery drug screening using mass spectrometry.
Siegel MM
Curr Top Med Chem; 2002 Jan; 2(1):13-33. PubMed ID: 11899063
[TBL] [Abstract][Full Text] [Related]
9. [Advances in the study of affinity selection-ultrafiltration/HPLC-MS].
Zhao HY; Zhang YZ; Xiao CL
Yao Xue Xue Bao; 2009 Oct; 44(10):1084-8. PubMed ID: 20055128
[TBL] [Abstract][Full Text] [Related]
10. A critical evaluation of high performance liquid chromatography-electrospray ionisation-mass spectrometry and capillary electrophoresis-electrospray-mass spectrometry for the detection and determination of small molecules of significance in clinical and forensic science.
Smyth WF; Brooks P
Electrophoresis; 2004 Jun; 25(10-11):1413-46. PubMed ID: 15188226
[TBL] [Abstract][Full Text] [Related]
11. Electrospray ionization mass spectrometry of oligonucleotide complexes with drugs, metals, and proteins.
Beck JL; Colgrave ML; Ralph SF; Sheil MM
Mass Spectrom Rev; 2001; 20(2):61-87. PubMed ID: 11455562
[TBL] [Abstract][Full Text] [Related]
12. HPLC-MS/MS in drug metabolism and pharmacokinetic screening.
Hsieh Y
Expert Opin Drug Metab Toxicol; 2008 Jan; 4(1):93-101. PubMed ID: 18370861
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
